Noteworthy, when we initially reported that autocrine SMAD signaling occurs in melanoma cells and is dependent upon secretion and pericellular activation of TGF-β [35], we did not know the expression status of SKI and SnoN protein in the various cell lines used in our studies. The gene discussed is TGFB1; the disease is melanoma.